Literature DB >> 30727759

Comparison of thromboelastometry by ROTEM® Delta and ROTEM® Sigma in women with postpartum haemorrhage.

Ada Gillissen1,2,3, Thomas van den Akker3,4, Camila Caram-Deelder1,2, Dacia D C A Henriquez1,2,3, Kitty W M Bloemenkamp5, Jeroen Eikenboom6, Johanna G van der Bom1,2, Moniek P M de Maat7.   

Abstract

Haemostatic treatment in women experiencing postpartum haemorrhage is increasingly based on point-of-care devices such as ROTEM® thromboelastometry. Recently, a fully automated successor of the ROTEM® Delta device, the ROTEM® Sigma was introduced. To determine whether these devices provide similar results, we compared ROTEM® parameters using the ROTEM® Delta and Sigma devices in women experiencing postpartum haemorrhage. Prospective observational cohort study of 23 women experiencing postpartum haemorrhage. ROTEM® INTEM, EXTEM, FIBTEM and APTEM measurements handled by the ROTEM® Delta and Sigma devices were compared. ROTEM® FIBTEM values were also related to Clauss fibrinogen values. A correlation of Spearman's r (rs) varying between 0.76 and 0.95 was displayed between clot firmness measured in millimeters at 5 (A5), 10 (A10) and 20 (A20) minutes after start of clot formation measured by EXTEM, INTEM and APTEM assays executed on both devices; A5, A10 and A20 of FIBTEM correlated less well (rS between 0.71 and 0.74), especially after five and ten minutes. Correlation between both devices regarding clotting time (CT) was poor. The observed correlation between levels of Clauss fibrinogen and FIBTEM A5 was rs = 0.70, (95% confidence interval (CI): 0.38 to 0.87) for Delta and rs = 0.85, (CI 0.65 to 0.94) for Sigma. A5, A10 and A20 measured in EXTEM, INTEM and APTEM obtained from ROTEM® Delta and Sigma devices were similar. EXTEM, FIBTEM and APTEM CT values from both devices showed no correlation. Substantial variation was found between FIBTEM assays of the devices. Consequently, results of FIBTEM assays should always be interpreted in the context of device-specific reference values. Correlation with Clauss fibrinogen was better in the ROTEM® Sigma device.

Entities:  

Keywords:  ROTEM Delta; ROTEM Sigma; Thromboelastometry; comparison; postpartum haemorrhage

Mesh:

Substances:

Year:  2019        PMID: 30727759     DOI: 10.1080/00365513.2019.1571220

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

Review 1.  Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices.

Authors:  Oksana Volod; Connor M Bunch; Nuha Zackariya; Ernest E Moore; Hunter B Moore; Hau C Kwaan; Matthew D Neal; Mahmoud D Al-Fadhl; Shivani S Patel; Grant Wiarda; Hamid D Al-Fadhl; Max L McCoy; Anthony V Thomas; Scott G Thomas; Laura Gillespie; Rashid Z Khan; Mahmud Zamlut; Peter Kamphues; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

Review 2.  Viscoelastic Hemostatic Assays for Orthopedic Trauma and Elective Procedures.

Authors:  Christiaan N Mamczak; Jacob Speybroeck; John E Stillson; Joseph Dynako; Andres Piscoya; Ethan E Peck; Michael Aboukhaled; Emily Cancel; Michael McDonald; Diego Garcia; John Lovejoy; Stephanie Lubin; Robert Stanton; Matthew E Kutcher
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

3.  A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study.

Authors:  Ryogo Yoshii; Teiji Sawa; Hidetake Kawajiri; Fumimasa Amaya; Kenichi A Tanaka; Satoru Ogawa
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

Review 4.  Viscoelastic Hemostatic Assays: Moving from the Laboratory to the Site of Care-A Review of Established and Emerging Technologies.

Authors:  Jan Hartmann; Matthew Murphy; Joao D Dias
Journal:  Diagnostics (Basel)       Date:  2020-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.